Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-025446
Filing Date
2014-04-29
Accepted
2014-04-28 18:29:41
Documents
3
Period of Report
2014-04-28

Document Format Files

Seq Description Document Type Size
1 6-K v376225_6k.htm 6-K 10468
2 EXHIBIT 99.1 v376225_ex99-1.htm EX-99.1 5911
3 GRAPHIC tlogo.jpg GRAPHIC 10122
  Complete submission text file 0001144204-14-025446.txt   31503
Mailing Address 8 SHAUL HAMELECH BLVD. AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address 8 SHAUL HAMELECH BLVD. AMOT HAMISHPAT BLDG. TEL AVIV L3 64733 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 14790760
SIC: 2834 Pharmaceutical Preparations